ANISOTROPY FUNCTIONS FOR PD-103, I-125, AND IR-192 INTERSTITIAL BRACHYTHERAPY SOURCES

Citation
R. Nath et al., ANISOTROPY FUNCTIONS FOR PD-103, I-125, AND IR-192 INTERSTITIAL BRACHYTHERAPY SOURCES, Medical physics, 20(5), 1993, pp. 1465-1473
Citations number
23
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
Journal title
ISSN journal
00942405
Volume
20
Issue
5
Year of publication
1993
Pages
1465 - 1473
Database
ISI
SICI code
0094-2405(1993)20:5<1465:AFFPIA>2.0.ZU;2-H
Abstract
Anisotropy of dose distributions around Pd-103, I-125, and Ir-192 sour ces for interstitial brachytherapy was examined. Dose rates around I-1 25 models 6702 and 6711 and Ir-192 sources were measured using lithium fluoride thermoluminescence dosimeters (LiF TLDs) in a water-equivale nt, solid phantom. From these measured data for I-125 and Ir-192 and t he previously published measured data for Pd-103, isodose rate contour s were determined using a bivariate interpolation and smooth surface f itting algorithm. The anisotropy functions, F(r,theta), as defined by the Interstitial Collaborative Working Group (ICWG) for each source, w ere determined. Also, 4pi-averaged anisotropy factors, phi(an)(r), for use in point source approximation, have been calculated at radial dis tances varying from 1-10 cm for Pd-103, I-125, and Ir-192 sources. The anisotropy factors had average values of 0.90, 0.93, 0.95, and 0.98 f or Pd-103, I-125 model 6711, model 6702, and Ir-192, respectively. The anisotropy factors determined from dose measurements in phantom are o bserved to be closer to unity than from those determined previously fr om in-air measurements. This can be attributed to the smoothing of two -dimensional dose distributions due to the presence of more scattered photons in the phantom measurements compared to in-air measurements. B ecause in-phantom measurements simulate more closely the brachytherapy patient, data from these experiments are recommended for a more accur ate determination of dose distributions around clinical brachytherapy implants. In this work, we present a complete set of source data for t wo-dimensional dosimetry following the ICWG formalism.